|
ISIN No
|
INE031B01049
|
BSE Code / NSE Code
|
532331 / AJANTPHARM
|
Book Value (Rs.)
|
362.42
|
Face Value
|
2.00
|
|
Bookclosure
|
05/08/2026
|
52Week High
|
3599
|
EPS
|
84.54
|
P/E
|
40.69
|
|
Market Cap.
|
42968.51 Cr.
|
52Week Low
|
2330
|
P/BV / Div Yield (%)
|
9.49 / 0.81
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
| YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
| 2603 |
Investments in Non-Convertible Debentures
| NCD | Others | 208.34 |
| 2603 |
Investment in Mutual Funds
| Mutual Fund Scheme | Mutual Fund | 125.35 |
| 2603 |
Investment in Commercial Papers
| Commercial Paper | Others | 111.47 |
| 2603 |
Investments in Non-Convertible Debentures.
| NCD | Others | 110.11 |
| 2603 |
ABCD Technologies LLP
| Others | Partnership Firm | 28.50 |
| 2603 |
Ajanta Pharma (Mauritius) Ltd.
| Equity Share | Subsidiary | 9.44 |
| 2603 |
Ajanta Pharma USA Inc.
| Equity Share | Subsidiary | 7.07 |
| 2603 |
Alternative Investment CAT-II
| Others | Others | 4.58 |
|